DOCSLIB.ORG

ICD-9 to ICD-10 Code Conversion Table for Assisted Reproduction

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ICD-9 to ICD-10 Code Conversion Table for Assisted Reproduction ICD-9 to ICD-10 Code Conversion Table for Assisted Reproduction Codes arranged alphabetically by desriptor ICD-9-CM Description ICD-10-CM 568 Abdominal Adhesions K66.0 789 Abdominal Pain NOS R10.9 633 Abdominal pregnancy O00.0 789.6 Abdominal tenderness (rebound) R10.819 793.5 Abnormal Radiology exam (HSG, USG) R93.8 792.2 Abnormal Sperm Morphology R86.8 637.9 Abortion Incomplete Z33.2 701.8 Acanthosis Nigricans L91.8 V88.03 Acquired absence of cervix with uterus remaining Z90.712 Acute vaginitis N76.0 614 Acute salpingitis and oophoritis N70.0 Acute vulvitis N76.2 219 Adenomatous Polyp of Cervix D26.0 617 Adenomyosis N80.0 789.3_ Adnexal mass R or L R19.03 752.31 Agenesis and aplasia of uterus and cervix Q51.0 626 Amenorrhea (Primary) N91.0 Amenorrhea (Secondary) N91.1 256.1 Androgen Excess E28.1 259.51 Androgen Insensitivity Syndrome, complete E34.51 259.52 Androgen Insensitivity Syndrome, partial E34.52 255.2 Androgenital Syndrome E25.0 608.87 Anejaculatory Orgasm N53.13 V78.0 Anemia (rule out) lab test Z13.0 628 Anovulation N97.0 752.36 Arcuate uterus Q51.0 V26.1 Artificial Insemination Z31.89 789.59 Ascites, other R18.8 245.2 Autoimmune thyroiditis E06.3 606 Azoospermia N46.01 221.8 Benign teratoma D28.7 623.8 Bleeding, Vaginal N89.8 631.8 Blighted Ovum O02.0 611.72 Breast Lump N63 180 Cancer ,cervix (canal) C53.0 233.1 Cancer, cervix (in situ) D06.9 182 Cancer, endometrium C54.1 183 Cancer, ovarian C56.9 233.3 Cancer, Vagina (in situ) D07.30 V83.89 Carrier of Defective Gene Z14.8 682.5 Cellulitis, buttock, gluteal L03.317 622.8 Cervical Abnormality, DES N88.8 622.4 Cervical Stenosis N88.2 616 Cervicitis N72 V83.81 CF gene carrier Z14.1 277.09 CF, unspecified E84.9 338.4 Chronic Pain syndrome G89.4 614.1 Chronic salpingitis and oophoritis N70.1 **Please note this document was developed by the ASRM Coding Committee as a resource for our members. Please confirm codes with the appropriate reference. Last updated 3.18.2014. ICD-9 to ICD-10 Code Conversion Table for Assisted Reproduction Codes arranged alphabetically by desriptor ICD-9-CM Description ICD-10-CM 630 Classical hydatidiform mole O01.0 639 Complication following ectopic and molar pregnancy O08 255.2 Congenital Adrenal Hyperplasia E25.0 752.89 Congenital Bilateral Absence of the Vas Deferens N46.023 620.1 Corpus Luteum N83.1 276.51 Dehydration E86.0 259 Delayed Puberty E30.0 256.39 DOR/POF E28.39 752.2 Doubling of uterus with doubling of cervix and vagina Q51.1 …with obstruction Q51.11 …without obstruction Q51.10 626.8 Dysfunctional uterine bleeding, specified N93.8 Dysfunctional uterine bleeding, unspecified N93.9 625.3 Dysmenorrhea, primary N94.4 Dysmenorrhea, secondary N94.5 625 Dysparunia N94.1 633.9 Ectopic pregnancy, unspecified O00.9 782.3 Edema Generalized R60.1 Localized R60.0 Unspecified R60.9 V59.71 Egg Donor, < 35, anonymous Z52.810 V59.72 Egg Donor, <35, designated Z52.811 V59.73 Egg Donor, 35+, anonymous Z52.812 V59.74 Egg Donor, 35+, designated Z52.813 V59.70 Egg Donor, unspecified Z52.819 795.82 Elevated CA125 R97.1 V26.81 Encounter during IVF cycle Z31.83 V70.3 Encounter for Adoption Services Z02.82 V72.86 Encounter for Blood Typing Z01.83 V82.71 Encounter for nonprocreative screening for genetic disease carrier status Z13.71 V82.79 Encounter for other screening for genetic and chromosomal anomalies Z13.79 V72.4 Encounter for pregnancy test Z32.0 V72.41 …result negative Z32.02 V72.42 …result positive Z32.01 V72.40 …result unknown Z32.00 V73.89 Encounter for screening for HIV Z11.4 Encounter for screening for other infectious and parasitic diseases Z11.8 V73.3 Encounter for screening for other viral diseases (Rubella) Z11.59 V74.5 Encounter for screening for STD's Z11.3 621 Endometrial Polyp N84.0 621.31 Endometrial Hyperplasia, benign N85.01 617.6 Endometriosis in scar of skin N80.6 617.2 Endometriosis of fallopian tube N80.2 617.5 Endometriosis of intestine N80.5 617.8 Endometriosis of other specified sites N80.8 617.1 Endometriosis of ovary N80.1 617.3 Endometriosis of pelvic peritoneum N80.3 **Please note this document was developed by the ASRM Coding Committee as a resource for our members. Please confirm codes with the appropriate reference. Last updated 3.18.2014. ICD-9 to ICD-10 Code Conversion Table for Assisted Reproduction Codes arranged alphabetically by desriptor ICD-9-CM Description ICD-10-CM 617.4 Endometriosis of rectovaginal septum and vagina N80.4 617 Endometriosis of uterus N80.0 617.9 Endometriosis, site unspecified N80.9 615 Endometritis, acute N71.0 615.1 Endometritis, chronic N71.1 V25.49 Essure Procedure Z30.49 V70.8 Exam of potential donor Z00.5 628 Female Infertility associated with anovulation N97.0 Female Infertility associated with Stein-Leventhal Syndrome E28.2 628.4 Female Infertility of cervical origin N97.8 628.1 Female Infertility of hypothalamic pituitary origin E23.0 628.8 Female Infertility of other origin N97.8 628.2 Female Infertility of tubal origin N97.1 628.3 Female Infertility of uterine origin N97.2 628.9 Female Infertility, unspecified N97.9 V26.42 Fertility Preservation Counseling Z31.62 V26.82 Fertility Preservation Procedure Z31.84 V26.21 Fertility Testing Z31.41 780.6 Fever R50.2 610.1 Fibrocystic disease N60.1 793.5 Filling Defect R93.4 620 Follicular cyst N83.0 611.6 Galactorrhea N64.3 611.6 Galactorrhea not associated with childbirth N64.3 V26.33 Genetic Counseling Z31.5 629.9 Habitual Aborter N96 647.3 Habitual Aborter, Preg O26.21 621.4 Hematometra N85.7 620.8 Hematosalpinx N83.6 641.93 Hemorrhage, antepartum, unspecified O20.9 V23.9 High-risk preg. unspec. O09.90 704.1 Hirsutism L68.0 795.71 HIV, non specific evidence R75 614.1 Hydrosalpinx N70.11 255.3 Hyperadrenocorticism E27.0 643.03 Hyperemesis O21.0 251.1 Hyperinsulinism E16.1 253.1 Hyperprolactinemia E22.1 257.2 Hypogonadism, male E29.1 253.2 Hypopituitarism E23.0 244.9 Hypothyroidism, unspecified E03.9 631 Inappropriate rise in qhCG in early pregnancy O02.81 630 Incomplete and partial hydatidiform mole O01.1 251.8 Insulin Resistance E16.8 625.2 Intermenstrual (ovulation) pain N94.0 218.1 Intramural leiomyoma of uterus D25.1 621.5 Intrauterine Adhesions N85.6 758.7 Klinefelters syndrome Q98 **Please note this document was developed by the ASRM Coding Committee as a resource for our members. Please confirm codes with the appropriate reference. Last updated 3.18.2014. ICD-9 to ICD-10 Code Conversion Table for Assisted Reproduction Codes arranged alphabetically by desriptor ICD-9-CM Description ICD-10-CM 218.9 Leiomyoma of uterus, unspecified D25.9 789.04 LLQ pain R10.32 620.9 Luteal Phase defect N83.9 606 Male Infertility, azospermia N46.01 606.8 Male Infertility, Extra Testicular N46.029 606.1 Male Infertility, oligospermia N46.11 606.9 Male Infertility, unspecified N46.9 789.3 Mass, abdominal/pelvic R19.00 626.2 Menometrorrhagia/Menorrhagia N92.0 627.2 Menopausal Syndrome N95.1 626.4 Menstrual Irregularity N92.6 626.6 Metorrhagia N92.1 632 Missed Abortion O02.1 625.2 Mittelschmerz N94.0 V06.4 MMR vaccine Z23 278.01 Morbid Obesity E66.01 622.7 Mucous Polyp of the Cervix N84.1 752.3 Müllarian Anomaly Q51.0 752.31 Müllarian Anomaly Q51.0 V61.5 Multiparity Z64.1 787.02 Nausea R11.0 787 Nausea and Vomiting R11.2 Nontoxic diffuse goiter E04.0 Nontoxic goiter, unspecified E04.9 Nontoxic multinodular goiter E04.2 Nontoxic single thyroid nodule E04.1 278 Obesity E66.09 626.1 Oligomenorrhea, primary N91.3 Oligomenorrhea, secondary N91.4 606.1 Oligospermia N46.11 V26.89 Other special procreative management Z31.9 338.18 Other acute postoperative pain G89.18 752.2 Other doubling of uterus Q51.2 633.8 Other ectopic pregnancy O00.8 V26.29 Other Investigation and Testing Z31.49 Other nontoxic goiter E04._ Other specified nontoxic goiter E04.8 620.2 Ovarian cyst, unspecified N83.2 256.8 Ovarian Dysfunction E28.8 256.1 Ovarian hyperstimulation N98.1 E932.4 Ovarian hyperstimulation N98.1 633.2 Ovarian pregnancy O00.2 278.02 Overweight E66.3 626.5 Ovulation bleeding N92.3 614.6 Pelvic Adhesions N73.6 614.9 Pelvic Inflammatory Disease N73.9 625.8 Pelvic Pain N94.89 227.3 Pituitary Microadenoma D35.2 **Please note this document was developed by the ASRM Coding Committee as a resource for our members. Please confirm codes with the appropriate reference. Last updated 3.18.2014. ICD-9 to ICD-10 Code Conversion Table for Assisted Reproduction Codes arranged alphabetically by desriptor ICD-9-CM Description ICD-10-CM 511.9 Pleural Effusion J91.8 256.4 Polycystic Ovarian Syndrome E28.2 795.79 Positive APA panel R76.8 626.7 Postcoital bleeding N93.0 V67.00 Post-op follow-up Z09 998.5 Post-op Infection T81.4XXA 259.1 Precocious Puberty E30.1 V23.85 Pregnancy resulting from ART O09.811 V23.42 Pregnancy with history of ectopic O09.11 V23.87 Pregnancy with inconclusive fetal viability O36.80X0 V23.0 Pregnancy, History of Infertility O09.01 256.31 Premature Menopause E28.310 625.4 Premenstrual syndrome N94.3 V26.49 Procreative Counseling/Advice, other Z31.89 651.2_ Quadruplet pregnancy O30.2 Quadruplet pregnancy with 2 or more monoamniotic fetuses O30.22 …first trimester O30.211 Quadruplet pregnancy with 2 or more monochorionic fetuses O30.21 …first trimester O30.221 646.3 Recurrent Pregnancy Loss N96 608.87 Retrograde ejaculation N53.14 656.13 Rh Incompatibility O36.011 789.03 RLQ pain R10.31 646.33 SAb, Recurrent, currently pregnant O26.21 Salpingitis and oophoritis N70 614.2 Salpingitis and oophoritis, unspecified N70.9 Acute oophoritis N70.02 Acute salpingitis N70.01 Acute salpingitis and oophoritis N70.03 Chronic oophoritis N70.12 Chronic salpingitis N70.11 Chronic
Load more

Recommended publications
  • The Male Reproductive System
    Management of Men’s Reproductive 3 Health Problems Men’s Reproductive Health Curriculum Management of Men’s Reproductive 3 Health Problems © 2003 EngenderHealth. All rights reserved. 440 Ninth Avenue New York, NY 10001 U.S.A. Telephone: 212-561-8000 Fax: 212-561-8067 e-mail: [email protected] www.engenderhealth.org This publication was made possible, in part, through support provided by the Office of Population, U.S. Agency for International Development (USAID), under the terms of cooperative agreement HRN-A-00-98-00042-00. The opinions expressed herein are those of the publisher and do not necessarily reflect the views of USAID. Cover design: Virginia Taddoni ISBN 1-885063-45-8 Printed in the United States of America. Printed on recycled paper. Library of Congress Cataloging-in-Publication Data Men’s reproductive health curriculum : management of men’s reproductive health problems. p. ; cm. Companion v. to: Introduction to men’s reproductive health services, and: Counseling and communicating with men. Includes bibliographical references. ISBN 1-885063-45-8 1. Andrology. 2. Human reproduction. 3. Generative organs, Male--Diseases--Treatment. I. EngenderHealth (Firm) II. Counseling and communicating with men. III. Title: Introduction to men’s reproductive health services. [DNLM: 1. Genital Diseases, Male. 2. Physical Examination--methods. 3. Reproductive Health Services. WJ 700 M5483 2003] QP253.M465 2003 616.6’5--dc22 2003063056 Contents Acknowledgments v Introduction vii 1 Disorders of the Male Reproductive System 1.1 The Male
    [Show full text]
  • Prolactin Level in Women with Abnormal Uterine Bleeding Visiting Department of Obstetrics and Gynecology in a University Teaching Hospital in Ajman, UAE
    Prolactin level in women with Abnormal Uterine Bleeding visiting Department of Obstetrics and Gynecology in a University teaching hospital in Ajman, UAE Jayakumary Muttappallymyalil1*, Jayadevan Sreedharan2, Mawahib Abd Salman Al Biate3, Kasturi Mummigatti3, Nisha Shantakumari4 1Department of Community Medicine, 2Statistical Support Facility, CABRI, 4Department of Physiology, Gulf Medical University, Ajman, UAE 3Department of OBG, GMC Hospital, Ajman, UAE *Presenting Author ABSTRACT Objective: This study was conducted among women in the reproductive age group with abnormal uterine bleeding (AUB) to determine the pattern of prolactin level. Materials and Methods: In this study, a total of 400 women in the reproductive age group with AUB attending GMC Hospital were recruited and their prolactin levels were evaluated. Age, marital status, reproductive health history and details of AUB were noted. SPSS version 21 was used for data analysis. Descriptive statistics was performed to describe the population, and inferential statistics such as Chi-square test was performed to find the association between dependent and independent variables. Results: Out of 400 women, 351 (87.8%) were married, 103 (25.8%) were in the age group 25 years or below, 213 (53.3%) were between 26-35 years and 84 (21.0%) were above 35 years. Mean age was 30.3 years with a standard deviation 6.7. The prolactin level ranged between 15.34 mIU/l and 2800 mIU/l. The mean and SD observed were 310 mIU/l and 290 mIU/l respectively. The prolactin level was high among AUB patients with inter-menstrual bleeding compared to other groups. Additionally, the level was high among women with age greater than 25 years compared to those with age less than or equal to 25 years.
    [Show full text]
  • Endometriosis for Dummies.Pdf
    01_050470 ffirs.qxp 9/26/06 7:36 AM Page i Endometriosis FOR DUMmIES‰ by Joseph W. Krotec, MD Former Director of Endoscopic Surgery at Cooper Institute for Reproductive Hormonal Disorders and Sharon Perkins, RN Coauthor of Osteoporosis For Dummies 01_050470 ffirs.qxp 9/26/06 7:36 AM Page ii Endometriosis For Dummies® Published by Wiley Publishing, Inc. 111 River St. Hoboken, NJ 07030-5774 www.wiley.com Copyright © 2007 by Wiley Publishing, Inc., Indianapolis, Indiana Published by Wiley Publishing, Inc., Indianapolis, Indiana Published simultaneously in Canada No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning, or otherwise, except as permit- ted under Sections 107 or 108 of the 1976 United States Copyright Act, without either the prior written permission of the Publisher, or authorization through payment of the appropriate per-copy fee to the Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923, 978-750-8400, fax 978-646-8600. Requests to the Publisher for permission should be addressed to the Legal Department, Wiley Publishing, Inc., 10475 Crosspoint Blvd., Indianapolis, IN 46256, 317-572-3447, fax 317-572-4355, or online at http:// www.wiley.com/go/permissions. Trademarks: Wiley, the Wiley Publishing logo, For Dummies, the Dummies Man logo, A Reference for the Rest of Us!, The Dummies Way, Dummies Daily, The Fun and Easy Way, Dummies.com, and related trade dress are trademarks or registered trademarks of John Wiley & Sons, Inc., and/or its affiliates in the United States and other countries, and may not be used without written permission.
    [Show full text]
  • Dysmenorrhea Due to a Rare Müllerian Anomaly
    CASE REPORT Dysmenorrhea due to a rare müllerian anomaly M Agarwal, A Das, AS Singh Department of Obstetrics and Gynecology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences Shillong, India Abstract Müllerian duct anomalies may produce reproductive failure like abortion and preterm birth, or obstetric problems like malpresentation, retained placenta, etc., or they may be asymptomatic. Unicornuate uterus with a noncommunicating functional rudimentary horn is a type of müllerian anomaly that results in obstruction to menstrual blood flow, leading to endometriosis and dysmenorrhea. Though the majority of cases of dysmenorrhea in adolescents are primary in nature and require only reassurance and symptomatic management, it is important to be aware of rare causes such as müllerian anomalies so that these cases can be properly managed. Hence, we present this case report, with interesting illustrations, so as to increase awareness regarding these anomalies. Key words: Dysmenorrhea, müllerian anomaly, unicornuate uterus Date of Acceptance: 13-Feb-2011 Introduction department with complaints of severe pain in the lower abdomen during her menses for the last 6 months. Apart Unicornuate uterus with a rudimentary horn is a rare type from severe dysmenorrhea there was no other menstrual of müllerian duct malformation and is the result of defective abnormality. Her vitals and per abdominal examination fusion of the malformed duct with the contralateral duct.[1] findings were normal. Ultrasonography of the abdomen The incidence of unicornuate uterus, although not precisely suggested the possibility of unicornuate uterus with right- known, is estimated at 1/1000 women.[2] A noncommunicating sided hematosalpinx and hematometra; also, the right rudimentary horn with a functional endometrial cavity is rare kidney was not visualized.
    [Show full text]
  • Vaginitis and Abnormal Vaginal Bleeding
    UCSF Family Medicine Board Review 2013 Vaginitis and Abnormal • There are no relevant financial relationships with any commercial Vaginal Bleeding interests to disclose Michael Policar, MD, MPH Professor of Ob, Gyn, and Repro Sciences UCSF School of Medicine [email protected] Vulvovaginal Symptoms: CDC 2010: Trichomoniasis Differential Diagnosis Screening and Testing Category Condition • Screening indications – Infections Vaginal trichomoniasis (VT) HIV positive women: annually – Bacterial vaginosis (BV) Consider if “at risk”: new/multiple sex partners, history of STI, inconsistent condom use, sex work, IDU Vulvovaginal candidiasis (VVC) • Newer assays Skin Conditions Fungal vulvitis (candida, tinea) – Rapid antigen test: sensitivity, specificity vs. wet mount Contact dermatitis (irritant, allergic) – Aptima TMA T. vaginalis Analyte Specific Reagent (ASR) Vulvar dermatoses (LS, LP, LSC) • Other testing situations – Vulvar intraepithelial neoplasia (VIN) Suspect trich but NaCl slide neg culture or newer assays – Psychogenic Physiologic, psychogenic Pap with trich confirm if low risk • Consider retesting 3 months after treatment Trichomoniasis: Laboratory Tests CDC 2010: Vaginal Trichomoniasis Treatment Test Sensitivity Specificity Cost Comment Aptima TMA +4 (98%) +3 (98%) $$$ NAAT (like GC/Ct) • Recommended regimen Culture +3 (83%) +4 (100%) $$$ Not in most labs – Metronidazole 2 grams PO single dose Point of care – Tinidazole 2 grams PO single dose •Affirm VP III +3 +4 $$$ DNA probe • Alternative regimen (preferred for HIV infected
    [Show full text]
  • N35.12 Postinfective Urethral Stricture, NEC, Female N35.811 Other
    N35.12 Postinfective urethral stricture, NEC, female N35.811 Other urethral stricture, male, meatal N35.812 Other urethral bulbous stricture, male N35.813 Other membranous urethral stricture, male N35.814 Other anterior urethral stricture, male, anterior N35.816 Other urethral stricture, male, overlapping sites N35.819 Other urethral stricture, male, unspecified site N35.82 Other urethral stricture, female N35.911 Unspecified urethral stricture, male, meatal N35.912 Unspecified bulbous urethral stricture, male N35.913 Unspecified membranous urethral stricture, male N35.914 Unspecified anterior urethral stricture, male N35.916 Unspecified urethral stricture, male, overlapping sites N35.919 Unspecified urethral stricture, male, unspecified site N35.92 Unspecified urethral stricture, female N36.0 Urethral fistula N36.1 Urethral diverticulum N36.2 Urethral caruncle N36.41 Hypermobility of urethra N36.42 Intrinsic sphincter deficiency (ISD) N36.43 Combined hypermobility of urethra and intrns sphincter defic N36.44 Muscular disorders of urethra N36.5 Urethral false passage N36.8 Other specified disorders of urethra N36.9 Urethral disorder, unspecified N37 Urethral disorders in diseases classified elsewhere N39.0 Urinary tract infection, site not specified N39.3 Stress incontinence (female) (male) N39.41 Urge incontinence N39.42 Incontinence without sensory awareness N39.43 Post-void dribbling N39.44 Nocturnal enuresis N39.45 Continuous leakage N39.46 Mixed incontinence N39.490 Overflow incontinence N39.491 Coital incontinence N39.492 Postural
    [Show full text]
  • LNG-IUS) in Patients Affected by Menometrorrhagia, Dysmenorrhea and Adenomimyois: Clinical and Ultrasonographic Reports
    European Review for Medical and Pharmacological Sciences 2021; 25: 3432-3439 The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports F. COSTANZI, M.P. DE MARCO, C. COLOMBRINO, M. CIANCIA, F. TORCIA, I. RUSCITO, F. BELLATI, A. FREGA, G. COZZA, D. CASERTA Department of Surgical and Medical Sciences and Translational Medicine, Sant’Andrea University Hospital, Sapienza University of Rome, Rome, Italy Abstract. – OBJECTIVE: Adenomyosis is p=0.025; p=0.014). The blood loss decreased the consequence of the myometrial invasion significantly in both the cohorts (p<0.001) and by endometrial glands and stroma. Transvag- particularly in adenomyotic patients. Pain relief inal ultrasonography plays a decisive role in was observed in all the patients (p<0.001). the diagnosis and monitoring of this patholo- CONCLUSIONS: LNG-IUS can be considered gy. Our study aims to evaluate the efficacy of an effective treatment for managing symptoms LNG-IUS (Levonorgestrel Releasing Intrauter- and improving uterine morphology. ine System) as medical therapy. We analyzed both clinical symptoms and ultrasonograph- Key Words: ic aspects of menometrorrhagia and dysmen- Benign disease of uterus, Dysmenorrhea, Gyne- orrhea in patients with adenomyosis and the cologic imaging, Leiomyomas of the uterus/adeno- control group. myosis. PATIENTS AND METHODS: A prospective co- hort study was carried out on 28 patients suf- fering from symptomatic adenomyosis treat- ed with LNG-IUS. Adenomyosis was diagnosed Introduction through transvaginal ultrasonography by an ex- pert sonographer. A control group of 27 symp- Adenomyosis is a benign gynecological dis- tomatic patients (menorrhagia and dysmenor- ease with a large variety of clinical manifestation; rhea) without a transvaginal ultrasonograph- the most frequent include menorrhagia, metror- ic diagnosis of adenomyosis was treated in the rhagia, dysmenorrhea and chronic pelvic pain1.
    [Show full text]
  • Terminology for Describing Normally-Sited and Ectopic Pregnancies on Ultrasound: ESHRE Recommendations for Good Practice
    Terminology for describing normally-sited and ectopic pregnancies on ultrasound: ESHRE recommendations for good practice Set-up The invitation to review was sent to the members of the SIG Implantation and early pregnancy (n=7443 email addresses). In addition, the invitation was mailed to the members of the ESHRE Executive Committee and the Committee of National Representatives (n=74). An announcement was also placed on the eshre.eu website. The stakeholder review started on 20th of April 2020, and was closed after 4 weeks, on the 18th of May 2020. Summary Thirty reviewers, representing nineteen countries, submitted a total of 212 comments (on average 7 comments per reviewer). All reviewers are listed on page 2. IMPACT OF THE COMMENTS 9% General comment or language correction 25% Comments resulting in a change Comments to which a reply 66% was formulated This report comprises the list of reviewers, and the overview of comments, with a reply from the working group. Page 1 of 40 List of reviewers Name Country Organization Masoud Kamrava Iran Steven Goldstein USA Ulrike Metzger France Grigorios Derdelis Greece Luca Savelli Italy Gangaraju Buvaneswari India Mridu Sinha India Onur Erol Turkey Aboubakr Mohamed Elnashar Egypt Jiuzhi Zeng China Carlos Calhaz-Jorge Portugal Dr. Nidaa Qatar Attilio Di Spiezio Sardo Italy Melinda Mitranovici Romania Ali Sami Gurbuz Turkey Philippe Merviel France Roy Farquharson UK Ilan Timor USA Alessandra Pipan United Arab Emirates Company, Taiwan IVF Wen Jui Yang Taiwan Group Center Lorenzo Abad de Velasco Spain Monica Varma India Kumaran Aswathy India Annick Geril Belgium Snezana Vidakovic Serbia Lukasz Polanski, Miriam Baumgarten, Rebecca McKay, Laura Rutherford, Ouma Pillay, Anita Jeyaraj, Kanna Jayaprakasan and Kamal Ojha UK organization Mohamed Shahin UK Mohsen M El-Sayed UK International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) ISUOG European Niche taskforce group of the ESGE and international Prof.
    [Show full text]
  • Sonography in First Trimester Bleeding
    Review Sonography in First Trimester Bleeding Manjiri Dighe, MD,1 Carlos Cuevas, MD,1 Mariam Moshiri, MD,1 Theodore Dubinsky, MD,1 Vikram S. Dogra, MD2 1 Department of Radiology, University of Washington Medical Center, Seattle, WA 98195 2 Department of Imaging Sciences, University of Rochester School of Medicine, 601 Elmwood Avenue, Box 648, Rochester, NY 14642 Received 19 April 2007; accepted 1 October 2007 ABSTRACT: Vaginal bleeding is the most common however, the most common cause of bleeding is cause of presentation to the emergency department spotting caused by implantation of the conceptus in the first trimester. Approximately half of patients into the endometrium. A complete assessment of with first trimester vaginal bleeding will lose the preg- the first trimester pregnancy requires correlation nancy. Clinical assessment is difficult, and sonogra- of serum b human chorionic gonadotropin (b- phy is necessary to determine if a normal fetus is hCG) levels with the appearance of the gesta- present and alive and to exclude other causes of bleeding (eg, ectopic or molar pregnancy). Diagnosis tional sac (GS) using sonography. of a normal intrauterine pregnancy not only helps the physician in terms of management but also gives psy- SPONTANEOUS ABORTION chologic relief to the patient. Improved ultrasound technology and high-frequency endovaginal trans- Spontaneous abortion is defined as the termina- ducers have enabled early diagnosis of abnormal and tion of a pregnancy before the twentieth completed ectopic pregnancies, decreasing maternal morbidity week of gestation. Sixty-five percent of spontane- and mortality. The main differential considerations of ous abortions occur in the first 16 weeks of preg- first trimester bleeding are spontaneous abortion, ec- nancy.
    [Show full text]
  • Abnormal Uterine Bleeding: a Management Algorithm
    J Am Board Fam Med: first published as 10.3122/jabfm.19.6.590 on 7 November 2006. Downloaded from EVIDENCED-BASED CLINICAL MEDICINE Abnormal Uterine Bleeding: A Management Algorithm John W. Ely, MD, MSPH, Colleen M. Kennedy, MD, MS, Elizabeth C. Clark, MD, MPH, and Noelle C. Bowdler, MD Abnormal uterine bleeding is a common problem, and its management can be complex. Because of this complexity, concise guidelines have been difficult to develop. We constructed a concise but comprehen- sive algorithm for the management of abnormal uterine bleeding between menarche and menopause that was based on a systematic review of the literature as well as the actual management of patients seen in a gynecology clinic. We started by drafting an algorithm that was based on a MEDLINE search for rel- evant reviews and original research. We compared this algorithm to the actual care provided to a ran- dom sample of 100 women with abnormal bleeding who were seen in a university gynecology clinic. Discrepancies between the algorithm and actual care were discussed during audiotaped meetings among the 4 investigators (2 family physicians and 2 gynecologists). The audiotapes were used to revise the algorithm. After 3 iterations of this process (total of 300 patients), we agreed on a final algorithm that generally followed the practices we observed, while maintaining consistency with the evidence. In clinic, the gynecologists categorized the patient’s bleeding pattern into 1 of 4 types: irregular bleeding, heavy but regular bleeding (menorrhagia), severe acute bleeding, and abnormal bleeding associated with a contraceptive method. Subsequent management involved both diagnostic and treatment interven- tions, which often occurred simultaneously.
    [Show full text]
  • Too Much, Too Little, Too Late: Abnormal Uterine Bleeding
    Too much, too little, too late: Abnormal uterine bleeding Jody Steinauer, MD, MAS July, 2015 The Questions • Too much (& too early or too late) – Differential and approach to work‐up – Does she need an endometrial biopsy (EMB)? – Does she need an ultrasound? – How do I stop peri‐menopausal bleeding? – Isn’t it due to the fibroids? • Too fast: She’s hemorrhaging—what do I do? • Too little: A quick review of amenorrhea Case 1 A 46 yo G3P2T1 reports her periods have become 1. What term describes increasingly irregular and heavy her symptoms? over the last 6‐8 months. 2. Physiologically, what Sometimes they come 2 times causes this type of per month and sometimes there bleeding pattern? are 2 months between. LMP 2 3. What is the months ago. She bleeds 10 days differential? with clots and frequently bleeds through pads to her clothes. She occasionally has hot flashes. She also has diabetes and is obese. Q1: In addition to a urine pregnancy test and TSH, which of the following is the most appropriate test to obtain at this time? 1. FSH 2. Testosterone & DHEAS 3. Serum beta‐HCG 4. Transvaginal Ultrasound (TVUS) 5. Endometrial Biopsy (EMB) Terminology: What is abnormal? • Normal: Cycle= 28 days +‐ 7 d (21‐35); Length=2‐7 days; Heaviness=self‐defined • Too little bleeding: amenorrhea or oligomenorrhea • Too much bleeding: Menorrhagia (regular timing but heavy (according to patient) OR long flow (>7 days) • Irregular bleeding: Metrorrhagia, intermenstrual or post‐ coital bleeding • Irregular and Excessive: Menometrorrhagia • Preferred term for non‐pregnant bleeding issues= Abnormal Uterine Bleeding (AUB) – Avoid “DUB” ‐ dysfunctional uterine bleeding.
    [Show full text]
  • Left Twisted Hydrosalpinx Presenting As Acute Abdomen
    The Journal of Obstetrics and Gynecology of India January/February 2011 pg 81 - 82 Case Report Left Twisted Hydrosalpinx Presenting as Acute Abdomen Pawar Uddhav1, Ghanekar Mahendra2 Department of Obstetrics and Gynaecology, Goa Medical College, Goa . A 30-year-old para 3 not sterilized was admitted on hemorrhage within i.e. in other words a left twisted 18.01.2006 with a history of acute pain in the abdomen hematosalpinx (Fig. 1 & 2 – the red arrow showing the of one day duration. She was in the 10th day post hematosalpinx and the gloved hand holding the uterus). menstrual cycle.. There was no history of dysmenorrhea. From the rest of her history all other The left ovary was normal and rest of the pelvic non gynecological causes of acute abdomen were ruled structures did not reveal any pathology. Left out. salpingectomy was done and as the patient desired ligation, right sided tubal ligation was also carried out. On examination her vitals were stable barring a mild The patient was discharged on 24.01.2006. The tachycardia; pulse rate=94/min. Per abdomen postoperative period was uneventful. The patient was examination there was tenderness in the left iliac fossa, given IV ofloxacin and IV-metronidazole for 24 hrs and no guarding or rigidity and bowel sounds were present. then switched over to oral ofloxacin for 10 days. She Bimanual pelvic examination revealed normal sized was asked to follow up with the histopathology reports uterus with tender cystic mass in left adnexa after 15 days. She followed up on 11.02.2006. The report approximately 4X4 cm and cervical motion tenderness was: gross - tube dilated and tortuous appearing bluish was positive.
    [Show full text]